Please login to the form below

Not currently logged in
Email:
Password:

BIA elects six new board members

Biotech trade body adds representatives from MedImmune, J&J and more

BIA J and J Patrick VerheyenUK trade body the BioIndustry Association (BIA) has elected six new members to its board.

They comprise senior figures from different member companies of the organisation, which represents the biotech industry in the UK.

The list of new members includes Patrick Verheyen (pictured right), head of Johnson & Johnson's innovation centre in London; Jane Osbourn of AstraZeneca subsidiary MedImmune; and Kevin Cox, CEO of imaging firm Imanova.

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

They will all serve from January 1, 2014, for term of three years.

The BIA also announced several returning board members, including John Brown of Vectura Group and Ian Tomlinson, senior VP of worldwide business development and biopharma research at GlaxoSmithKline.

“The appointees are recognised leaders of our industry and I look forward to working with them to help the BIA meet the needs of the bioscience sector in Europe's strongest bioscience cluster,” said Edward Hodgkin, BIA chairman.

15th October 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics